Krohn K T
Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S576-8. doi: 10.1093/clinids/8.supplement_5.576.
In a single-blind randomized study, the efficacy of a single intravenous dose of sulbactam (0.5 g) plus ampicillin (1 g) was compared with that of placebo in the prophylaxis of early postoperative endometritis after abortion with vacuum aspiration in the first trimester. Administration of either sulbactam/ampicillin or placebo occurred immediately before the operation. The two treatment groups were equally matched with respect to patient's age, gestational age, presence of an intrauterine device, and baseline bacteriologic findings. During the first seven postoperative days, four of 145 patients who had received sulbactam/ampicillin and 11 of 140 patients who had received placebo were diagnosed as having endometritis. No adverse effects and no laboratory test abnormalities attributable to treatment were reported in either group. A single dose of sulbactam/ampicillin reduced the incidence of early postoperative endometritis after abortion with vacuum aspiration in the first trimester.
在一项单盲随机研究中,比较了单剂量静脉注射舒巴坦(0.5克)加氨苄西林(1克)与安慰剂预防早期妊娠行真空吸引流产术后子宫内膜炎的疗效。手术前即刻给予舒巴坦/氨苄西林或安慰剂。两个治疗组在患者年龄、孕周、宫内节育器的存在情况以及基线细菌学检查结果方面匹配良好。术后前七天,接受舒巴坦/氨苄西林治疗的145例患者中有4例被诊断为子宫内膜炎,接受安慰剂治疗的140例患者中有11例被诊断为子宫内膜炎。两组均未报告与治疗相关的不良反应及实验室检查异常。单剂量舒巴坦/氨苄西林降低了早期妊娠行真空吸引流产术后子宫内膜炎的发生率。